secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001171843-26-000210
Event type: other
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical TULSA-PRO installed base reaches 78 systems, exceeding 2025 target of 75
--------------------------------------------------------------------------------

- TULSA-PRO installed base stood at 78 systems as of Dec. 31, 2025, above the goal of 75.
- Qualified sales pipeline grew to 97 new systems in Verify, Negotiate, or Contracting stages.
- CEO expects higher patient treatment rates and recurring revenue as installed base expands.
- Q4 and full-year 2025 financial results to be released near end of February 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/0001171843-26-000210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/f8k_011226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-000210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer